BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Deals

  WIRB-Copernicus Group Acquires Vigilare International

  Financial details about the transaction were not disclosed.

  November 28, 2017

   · 

  2 min read
• Business

  Q BioMed Adds Boston University’s Dr. Tager-Flusberg to Advisory Committee

  Q Biomed announced today that Dr. Helen Tager-Flusberg from Boston University has joined its advisory committee for QBM-001, which is being tested for pediatric developmental nonverbal disorder in toddlers within the autism spectrum disorders.

  November 28, 2017

   · 

  5 min read
• Biotech Beach

  Biocept and UC San Diego Medical Center Announce Clinical Study Collaboration to Demonstrate Utility of Biocept’s Liquid Biopsy Test in Immunotherapy

  The 100-patient study is designed to clinically validate Biocept’s Target Selector PD-L1 assay for patients diagnosed with NSCLC.

  November 28, 2017

   · 

  5 min read
• Business

  Champions Oncology to Announce Second Quarter Financial Results on Thursday, December 7, 2017

  The company will host a conference call to discuss the results that day at 4:30 p.m. EST (1:30 p.m. PST).

  November 28, 2017

   · 

  1 min read
• Biotech Beach

  Ambry Genetics’ Mitochondrial Disease Research May Help Develop Treatments Sooner

  The power of dedicated research, and discovery of new gene mutation variants help develop much-needed treatments.

  November 28, 2017

   · 

  3 min read
• Drug Development

  PhaseRx Receives Positive Opinion for Orphan Drug Designation for PRX-ASL From EMA

  PhaseRx today announced that the EMA’s Committee for Orphan Medicinal Products has issued a positive opinion recommending orphan medicinal product designation for PRX-ASL, for the treatment of ASLD, PhaseRx’s second drug candidate to treat a urea cycle disorder.

  November 28, 2017

   · 

  5 min read
• BioForest

  University of Washington and Nortis Publish First Organ-on-Chip Study Modeling Human Liver-Kidney Interactions for Preclinical Pharmacology and Toxicology Studies

  The University of Washington used the Nortis ParVivo system in this study that was published in JCI Insights and highlighted as its cover article.

  November 28, 2017

   · 

  3 min read
• Business

  PURE Bioscience Sets Fiscal 2018 Q1 Financial Results Conference Call

  Management will also discuss the progress made to commercialize its two antimicrobial SDC-based food safety solution.

  November 28, 2017

   · 

  4 min read
• Drug Development

  Regentis Biomaterials Performs the First Cases in Gelrinc Pivotal Study

  Regentis Biomaterials announced today the start of its Phase III pivotal clinical trial of GelrinC for the treatment of focal knee cartilage defects with successful surgery on three patients in the U.S. and Denmark.

  November 28, 2017

   · 

  3 min read
• Business

  BiondVax Provides Third Quarter 2017 Financial Results and Update

  BiondVax today announced its financial results for the quarter ended September 30, 2017 and provided a business update.

  November 28, 2017

   · 

  15 min read